Christos P. Kyriakopoulos

Author

Also Known As

C.P. Kyriakopoulos, CHRISTOS P. KYRIAKOPOULOS, Christos Kyriakopoulos, Christos P Kyriakopoulos, Christos P. Kyriakopoulos

Publications

371

Citations

H-Index

Concepts

All Affiliations

University of Utah Intermountain Medical Center Norwegian Womens Public Health Association Huntsman Cancer Institute Bon Secours Heart & Vascular Institute

About

Christos P. Kyriakopoulos is an author at University of Utah.

Christos P. Kyriakopoulos

Publications

274

Citations

H-Index

Page 1

	Year	Citations
Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support Stavros G. Drakos, Rachit Badolia, Aman Makaju, Circulation	2022	47
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages Palak Shah, Mitchell A. Psotka, Iosif Taleb, Circulation Heart Failure	2021	46
FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure Salah Sommakia, Naredos H. Almaw, Sandra H. Lee, Circulation Heart Failure	2021	33
Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support Nikolaos Diakos, Iosif Taleb, Christos P. Kyriakopoulos, Journal of the American Heart Association	2021	32
Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support Iosif Taleb, Christos P. Kyriakopoulos, Robyn Fong, JAMA Cardiology	2024	20
A Latent Cardiomyocyte Regeneration Potential in Human Heart Disease Wouter Derks, Julian Rode, Sofia Collin, Circulation	2024	19
Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart Yankun Lyu, Vipin Verma, Younjee Lee, npj Aging and Mechanisms of Disease	2021	17
Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer. Sofia Palacio, Arturo Loaiza‐Bonilla, Muaiad Kittaneh, PubMed	2014	16
Artificial intelligence predictive analytics in heart failure: results of the pilot phase of a pragmatic randomized clinical trial Konstantinos Sideris, Charlene Weir, Carsten Schmalfuss, Journal of the American Medical Informatics Association	2024	12
Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality Miguel Chavez, McHale Anderson, Christos P. Kyriakopoulos, Circulation Heart Failure	2024	12

Page 1